Immix Biopharma, Inc. (IMMX) stock

IMMXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30

$7.84−0.23 (-2.85%)

Close on Nov 13, 2026Market cap $560.87MP/E –Yield –

Immix Biopharma profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Immix Biopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?